分子靶向药物在肝癌治疗中的应用.pdf
文本预览下载声明
560 2011 5 18 5 Chin J Bases Clin General Surg, Vol. 18, o. 5, May 2011
1007- 9424( 2011) 05- 0560- 04
Application of Molecular Targeted Drugs in Therap of Hepatocellular Carcinoma
高军*
; ; ; ;
R735.7 C
[ 5]
,5
,, 3 , ,
, 62.6 / , ,
[1]
60 / 3 ,
, 90% ( HCC) , 10% ,
(ICC) ( MHC) , ,
, , (epidermal growth factor re
,15% ; ceptor, EGFR)
, , VEGF ,
, mTOR
(
HCC , ) ,
,
, 30 1
[2] 1. 1 (sorafenib)
, ( )
,
[ 3] ,
,
RAS/ RAF/ MEK/ ERK
,
,, ,
RAF/ MEK/ ERK 3( PI3K) / 2(VEGFR2)
AKP/ (mTOR) , ( PDGFR) ,
[ 4] , VEGF
(p53 PTE )
, ,
,
(EGF) (PDGF) 2007 43 ( ASCO) ,
[6]
( VEGF), Llovet HCC
,, , SHARP(Sor
afenib HCC Assessment Rand
显示全部